In the U.S., CVD is the leading cause of death, constitutes 17% of healthcare costs, and is estimated to increase in prevalence by ~10% and direct costs by almost three-fold over the next 20 years under current CVD prevention and treatment regimes [2]
A subcutaneous (under-the-skin) vial format exists, but the dose volume math makes injection awkward at common doses
Apply the cream to thoroughly cleansed, dried and toned skin.
Supplementing a minimum of 1g per day, is recommended to illicit any potential ergogenic benefit
This protects the peptide structure and ensures even dissolution
The company describes working with insurance carriers to determine coverage, but coverage details, pricing, and terms vary by plan